Entropy Technologies LP Invests $391,000 in GRAIL, Inc. $GRAL

Entropy Technologies LP bought a new stake in shares of GRAIL, Inc. (NASDAQ:GRAL) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,600 shares of the company’s stock, valued at approximately $391,000.

Several other institutional investors also recently added to or reduced their stakes in GRAL. Teacher Retirement System of Texas lifted its holdings in GRAIL by 5.5% during the 2nd quarter. Teacher Retirement System of Texas now owns 8,538 shares of the company’s stock valued at $439,000 after buying an additional 447 shares in the last quarter. Parallel Advisors LLC increased its position in shares of GRAIL by 24.1% during the second quarter. Parallel Advisors LLC now owns 2,313 shares of the company’s stock worth $119,000 after acquiring an additional 449 shares during the period. Crown Wealth Group LLC boosted its holdings in shares of GRAIL by 5.9% in the second quarter. Crown Wealth Group LLC now owns 8,986 shares of the company’s stock valued at $462,000 after purchasing an additional 500 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company’s stock valued at $76,000 after purchasing an additional 623 shares during the period. Finally, HighTower Advisors LLC grew its stake in GRAIL by 5.7% in the first quarter. HighTower Advisors LLC now owns 11,591 shares of the company’s stock worth $296,000 after purchasing an additional 627 shares in the last quarter.

GRAIL Stock Performance

GRAIL stock opened at $107.69 on Wednesday. The stock has a market cap of $4.20 billion, a PE ratio of -9.26 and a beta of 4.31. The stock has a 50-day moving average of $74.61 and a two-hundred day moving average of $51.28. GRAIL, Inc. has a one year low of $16.10 and a one year high of $115.76.

GRAIL (NASDAQ:GRAL) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.40) by $0.94. The firm had revenue of $36.19 million for the quarter, compared to the consensus estimate of $33.83 million. GRAIL had a negative net margin of 286.43% and a negative return on equity of 15.69%. As a group, sell-side analysts predict that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on GRAL. Canaccord Genuity Group lifted their target price on GRAIL from $85.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, November 17th. UBS Group set a $75.00 price objective on GRAIL in a report on Friday, October 3rd. Weiss Ratings reiterated a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Finally, Guggenheim upgraded shares of GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, November 12th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $75.00.

Insider Buying and Selling

In related news, President Joshua J. Ofman sold 81,385 shares of the company’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $62.50, for a total value of $5,086,562.50. Following the transaction, the president directly owned 396,797 shares of the company’s stock, valued at $24,799,812.50. This represents a 17.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert P. Ragusa sold 7,239 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total value of $498,622.32. Following the completion of the transaction, the chief executive officer owned 727,388 shares of the company’s stock, valued at $50,102,485.44. This trade represents a 0.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 113,295 shares of company stock worth $7,380,888 in the last 90 days.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.